Jennifer A. Westwood

Jennifer A. Westwood

Auto-generated profile, based on publicly available information

Jennifer A. Westwood

Department of Cancer Experiences Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2017 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
APAmanda Pereira-Salgado
Amanda Pereira-Salgado
JWJennifer A Westwood
Jennifer A Westwood
LRLahiru Russell
Lahiru Russell
AUAnna Ugalde
Anna Ugalde
BOBronwen Ortlepp
Bronwen Ortlepp
PSPenelope Schofield
Penelope Schofield
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.

2 March 2007 in Cancer Gene Therapy
Verified
Journal Article
Open access
PDF file
AMA Murphy
A Murphy
JWJ A Westwood
J A Westwood
LBLorena Brown
Lorena Brown
MTM W L Teng
M W L Teng
MMM Moeller
M Moeller
Michael KershawMichael Kershaw
Michael Kershaw
Activation and expansion of T cells are important in disease resolution, but tumors do not usually satisfy these immune requirements. Therefore, we employed a novel strategy whereby dual-specific T cells were generated that could respond to both tumor and influenza virus, reasoning that immunization with influenza virus would activate and expand tumor-specific cells, and inhibit tumor growth. Dual-specific T cells were generated by gene modification of influenza virus-specific mouse T cells with a chimeric gene-encoding reactivity against the erbB2 tumor-associated antigen. Dual-specific T cells were demonstrated to respond against both tumor and influenza in vitro, and expanded in vitro in response to influenza to a much greater degree than in response to tumor cells. Following adoptive transfer and immunization of tumor-bearing mice with influenza virus, dual-specific T cells expanded greatly in numbers in the peritoneal cavity and spleen. This resulted in a significant increase in time of survival of mice. However, tumors were not eradicated, which may have been due to the observed poor penetration of tumor by T cells. This is the first demonstration that the potent immunogenic nature of an infectious agent can be utilized to directly impact on T-cell expansion and activity against tumor in vivo.

1 August 2014 in Leukemia Research
Verified
Journal Article
Closed access
JWJennifer A. Westwood
Jennifer A. Westwood
GMGeoffrey M. Matthews
Geoffrey M. Matthews
JSJake Shortt
Jake Shortt
DFDavid Faulkner
David Faulkner
HPHollie J. Pegram
Hollie J. Pegram
Michael KershawMichael Kershaw
Michael Kershaw

4 June 2010 in The Open Gene Therapy Journal
Verified
Journal Article
Open access
JWJennifer A. Westwood
Jennifer A. Westwood
PMPreethi Mayura-Guru
Preethi Mayura-Guru
WMWilliam K Murray
William K Murray
HPHollie J. Pegram
Hollie J. Pegram
SASally M. Amos
Sally M. Amos
Michael KershawMichael Kershaw
Michael Kershaw